AGENDA

Following registration and opening remarks on Wednesday 22nd May, there will be a programme of panel discussions, presentations and workshops running in parallel. Further sessions and all timings will be added shortly.

Wednesday 22 May 2019

PANEL DISCUSSIONS

DELEGATES ARE FREE TO CHOOSE FROM TRACK 1,2 or 3 AT ANY TIME. PLEASE CLICK ON THE SESSION TITLE FOR FULL DESCRIPTION.

  Track 1:
Models, money and momentum: positioning for investment and growth
Track 2:
Going from concept to clinic for disruptive therapies
Track 3:
Driving development by engaging with patients, clinicians and regulators
08:00 – 08:50 Registration and networking
08:50 – 09:05 Welcome and opening remarks
Presented by Darrin Disley OBE, Chief Executive Officer, Mogrify
09:05 – 09:25 Interview with
Andy Richards CBE, Chairman, Congenica
Interview conducted by Mike Ward, Chief Content Officer, Informa Pharma Intelligence
09:25 – 09:45 Interview with
Chris Doherty, Managing Director, Alderley Park
Interview conducted by Mike Ward, Chief Content Officer, Informa Pharma Intelligence
09:45 – 10:05 Interview with
Mary Kerr, Chief Executive Officer at KaNDy Therapeutics & NeRRe Therapeutics
Interview conducted by Barbara Domayne-Hayman, Entrepreneur-in-residence, Francis Crick Institute

10:10 – 11:10 Funding for R&D platform technologies How can you drive the adoption of innovative technologies in R&D? Patient Engagement Strategies to Increase Clinical Study Awareness
11:10 – 11:40 Networking refreshment break
11.40 – 12:40  What investors look for during due diligence One-stop shop or specialist supply chain: how do you select the right providers? Winning outsourced contracts and effective business development
12:40 – 13:50 Networking luncheon
13:50 – 14:50  Collaborating across the value chain to translate great science into medicines Developing an integrated go-to-market strategy for autologous gene & cell therapies ATMPs system wide challenges from innovation to uptake – pragmatic supportive regulation and standards
14:55 – 15:55  Nailing your exit strategy: sell, partner or go it alone Outsourcing and Biomanufacturing Emerging Therapies: Challenges and Opportunities  Government supports the catapults for industry – is industry getting the most out of the catapults?
15:55 – 16:55 Networking drinks reception
16:55 Close
Register now

Wednesday 22 May 2019

PANEL DISCUSSIONS

DELEGATES ARE FREE TO CHOOSE FROM TRACK 1,2 or 3 AT ANY TIME. PLEASE CLICK ON THE SESSION TITLE FOR FULL DESCRIPTION.

  Track 1:
Models, money
and momentum:
positioning for investment
and growth
08:00 – 08:50 Registration and networking
08:50 – 09:05 Welcome and opening remarks
Presented by Darrin Disley OBE,
Chief Executive Officer, Mogrify
09:05 – 09:25 Interview with
Andy Richards CBE,
Chairman, Congenica
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:25 – 09:45 Interview with
Chris Doherty, Managing
Director, Alderley Park
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:45 – 10:05 Interview with
Mary Kerr, Chief Executive
Officer at KaNDy Therapeutics &
NeRRe Therapeutics
Interview conducted by Barbara
Domayne-Hayman,
Entrepreneur-in-residence,
Francis Crick Institute
10:10 – 11:10 Funding
for R&D platform technologies
11:10 – 11:40
Networking refreshment
break
11:40 – 12:40  What investors look for
during due diligence
12:40 – 13:50
Networking luncheon
13:50 – 14:50 Collaborating across the
value chain to translate
great science into medicines
14:55 – 15:55  Nailing your exit
strategy: sell, partner or go it
alone
15:55 – 16:55 Networking drinks reception
16:55 Close
  Track 2:
Going from concept
to clinic for
disruptive therapies
08:00 – 08:50 Registration and networking
08:50 – 09:05 Welcome and opening remarks
Presented by Darrin Disley OBE,
Chief Executive Officer, Mogrify
09:05 – 09:25
Interview with
Andy Richards CBE,
Chairman, Congenica
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:25 – 09:45 Interview with
Chris Doherty, Managing
Director, Alderley Park
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:45 – 10:05 Interview with
Mary Kerr, Chief Executive Officer
at KaNDy Therapeutics & NeRRe
Therapeutics
Interview conducted by Barbara
Domayne-Hayman, Entrepreneur
in-residence, Francis Crick
Institute
10:10 – 11:10 How can you drive the adoption
of innovative technologies
in R&D?
11:10 – 11:40
Networking refreshment
break
11:40 – 12:40 One-stop shop
or specialist supply chain:
how do
you select the
right providers?
12:40 – 13:50 Networking luncheon
13:50 – 14:50 Developing an integrated
go-to-market strategy for
autologous gene & cell
therapies
14:55-15:55 Outsourcing and Biomanufacturing
Emerging Therapies:
Challenges and
Opportunities
15:55 – 16:55 Networking drinks reception

16:55 Close
  Track 3:
Driving development
by engaging with
patients, clinicians
and regulators
08:00 – 08:50 Registration and networking
08:50 – 09:05 Welcome and opening remarks
Presented by Darrin Disley OBE,
Chief Executive Officer, Mogrify
09:05 – 09:25
Interview with
Andy Richards CBE,
Chairman, Congenica
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:25 – 09:45 Interview with
Chris Doherty, Managing
Director, Alderley Park
Interview conducted by Mike
Ward, Chief Content Officer,
Informa Pharma Intelligence
09:45 – 10:05 Interview with
Mary Kerr, Chief Executive Officer
at KaNDy Therapeutics &
NeRRe Therapeutics
Interview conducted by Barbara
Domayne-Hayman, Entrepreneur
in-residence, Francis Crick
Institute
10:10 – 11:10 Patient Engagement Strategies
to Increase Clinical
Study Awareness
11:10 – 11:40
Networking refreshment
break
11:40 – 12:40 Winning outsourced
contracts and effective
business development
12:40 – 13:50 Networking luncheon
13:50 – 14:50 ATMPs system
wide challenges from
innovation to uptake –
pragmatic supportive
regulation and standards
14:55 – 15:55  Government supports the
Catapults for industry
– is industry getting the
the most out of the catapults?
15:55 – 16:55 Networking drinks reception

16:55 Close
Register today